47 related articles for article (PubMed ID: 24237577)
1. Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country.
Iqbal J; Ali Z; Khan AU; Aziz Z
Leuk Lymphoma; 2014 Sep; 55(9):2109-13. PubMed ID: 24237577
[TBL] [Abstract][Full Text] [Related]
2. The effects of imatinib on pregnancy outcome.
Pye SM; Cortes J; Ault P; Hatfield A; Kantarjian H; Pilot R; Rosti G; Apperley JF
Blood; 2008 Jun; 111(12):5505-8. PubMed ID: 18322153
[TBL] [Abstract][Full Text] [Related]
3. Patient- versus physician-reporting of symptoms and health status in chronic myeloid leukemia.
Efficace F; Rosti G; Aaronson N; Cottone F; Angelucci E; Molica S; Vignetti M; Mandelli F; Baccarani M
Haematologica; 2014 Apr; 99(4):788-93. PubMed ID: 24241488
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy outcome in chronic myeloid leukemia patients on imatinib therapy.
Mukhopadhyay A; Dasgupta S; Kanti Ray U; Gharami F; Bose CK; Mukhopadhyay S
Ir J Med Sci; 2015 Mar; 184(1):183-8. PubMed ID: 24590821
[TBL] [Abstract][Full Text] [Related]
5. Managing pregnancy in chronic myeloid leukaemia.
Palani R; Milojkovic D; Apperley JF
Ann Hematol; 2015 Apr; 94 Suppl 2():S167-76. PubMed ID: 25814083
[TBL] [Abstract][Full Text] [Related]
6. [A female chronic myeloid leukemia patient who gave birth after stopping imatinib intentionally but who maintained a major molecular response with interferon].
Osawa T; Takahashi T; Yasuda M; Umeda M; Nagaya K; Tachi T; Goto H; Kasahara S; Teramachi H; Goto C
Gan To Kagaku Ryoho; 2015 Apr; 42(4):477-9. PubMed ID: 25963696
[TBL] [Abstract][Full Text] [Related]
7. [A case of lacrimal duct obstruction caused by capecitabine].
Noguchi Y; Mitani T; Kawara H; Tokuyama Y; Tamura Y; Uchiyama K; Shimizu Y
Gan To Kagaku Ryoho; 2015 Jan; 42(1):123-5. PubMed ID: 25596694
[TBL] [Abstract][Full Text] [Related]
8. Management of chronic myelogenous leukemia in pregnancy.
Bhandari A; Rolen K; Shah BK
Anticancer Res; 2015 Jan; 35(1):1-11. PubMed ID: 25550528
[TBL] [Abstract][Full Text] [Related]
9. Olanzapine-induced triglyceride and aminotransferase elevations without weight gain or hyperglycemia normalized after switching to aripiprazole.
Pawelczyk T; Pawelczyk A; Rabe-Jablonska J
J Psychiatr Pract; 2014 Jul; 20(4):301-7. PubMed ID: 25036587
[TBL] [Abstract][Full Text] [Related]
10. Chronic myeloid leukemia diagnosed in pregnancy: management and outcome of 87 patients reported to the European LeukemiaNet international registry.
Chelysheva E; Apperley J; Turkina A; Yassin MA; Rea D; Nicolini FE; Barraco D; Kazakbaeva K; Saliev S; Abulafia AS; Al-Kindi S; Byrne J; Robertson HF; Cerrano M; Shmakov R; Polushkina E; de Fabritiis P; Trawinska MM; Abruzzese E
Leukemia; 2024 Apr; 38(4):788-795. PubMed ID: 38388649
[TBL] [Abstract][Full Text] [Related]
11. Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an Indian tertiary care institution.
R C; Malik PS; Sahoo RK; Sharawat S; Singh M; Garg V; Bhatia K; Kantak A; Kumar S; Kumar L
Ann Hematol; 2023 Aug; 102(8):2087-2096. PubMed ID: 37322094
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Tyrosine Kinase Inhibitors on Fatherhood in Patients With Chronic Myeloid Leukemia: A Mixed-Method Study.
Abu-Tineh M; Ali EA; Alshurafa A; Nashwan AJ; Albsheer K; Ahmed A; Hailan Y; Rozi W; Aljaloudi E; Yassin MA
Cureus; 2023 Jan; 15(1):e33407. PubMed ID: 36751250
[TBL] [Abstract][Full Text] [Related]
13. Fertility considerations in targeted biologic therapy with tyrosine kinase inhibitors: a review.
Rambhatla A; Strug MR; De Paredes JG; Cordoba Munoz MI; Thakur M
J Assist Reprod Genet; 2021 Aug; 38(8):1897-1908. PubMed ID: 33826052
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy outcomes of women whom spouse fathered children after tyrosine kinase inhibitor therapy for chronic myeloid leukemia: A systematic review.
Szakács Z; Hegyi PJ; Farkas N; Hegyi P; Balaskó M; Erős A; Szujó S; Pammer J; Mosdósi B; Simon M; Nagy A; Für G; Hussain A
PLoS One; 2020; 15(12):e0243045. PubMed ID: 33270732
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcomes in patients treated with bosutinib.
Cortes JE; Gambacorti-Passerini C; Deininger M; Abruzzese E; DeAnnuntis L; Brümmendorf TH
Int J Hematol Oncol; 2020 May; 9(2):IJH26. PubMed ID: 33005329
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy Outcomes in Chronic Myeloid Leukemia: A Single Center Experience.
Madabhavi I; Sarkar M; Modi M; Kadakol N
J Glob Oncol; 2019 Sep; 5():1-11. PubMed ID: 31584851
[TBL] [Abstract][Full Text] [Related]
17. Fetal Toxicity of Immunosuppressive Drugs in Pregnancy.
Ponticelli C; Moroni G
J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30558290
[TBL] [Abstract][Full Text] [Related]
18. Chronic Myeloid Leukemia and Cesarean Section: The Anesthesiologist's Point of View.
Rebahi H; Ait Sliman M; El Adib AR
Case Rep Obstet Gynecol; 2018; 2018():3138718. PubMed ID: 30319826
[TBL] [Abstract][Full Text] [Related]
19. Gonadotoxic Effects of Nilotinib in Chronic Myeloid Leukemia Treatment Dose in a Mouse Model.
Cengiz Seval G; Özkavukçu S; Seval M; Aylı M
Turk J Haematol; 2017 Jun; 34(2):137-142. PubMed ID: 27466938
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy and Accelerated Phase of Myeloid Chronic Leukemia Treated with Imatinib: A Case Report from a Developing Country.
Ngolet LO; Kocko I; Elira Dokekias A
Case Rep Hematol; 2016; 2016():6104948. PubMed ID: 27123350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
